Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity


Por: Riera, P, Salazar, J, Virgili, AC, Tobena, M, Sebio, A, Gallano, P, Barnadas, A, Paez, D

Publicada: 1 jun 2018
Resumen:
Severe irinotecan-induced toxicity is associated with UGT1A1 polymorphisms. However, some patients develop side-effects despite harbouring a normal UGT1A1 genotype. As CYP3A4 is also an irinotecan-metabolizing enzyme, our study aimed to elucidate the influence of the CYP3A4*20 loss-of-function allele in the toxicity profile of these patients. Three-hundred and eight metastatic colorectal cancer patients treated with an irinotecan-containing chemotherapy were studied. The presence of CYP3A4*20, UGT1A1*37 and UGT1A1*28 alleles was tested. Associations between these genetic variants and toxicity were evaluated. UGT1A1*28 was significantly associated with severe diarrhoea, neutropenia and asthenia (P = 0.002, P = 0.037 and P = 0.041, respectively). One patient with the UGT1A1*28/*37 genotype presented with grade IV neutropenia and lethal septic shock. One heterozygous UGT1A1 (*1/*28) patient also carried the CYP3A4*20 allele but did not develop toxicity. We confirm that UGT1A1*37 and UGT1A1*28 are associated with severe toxicity and suggest that the CYP3A4*20 allele does not play a role in irinotecan-induced toxicity.

Filiaciones:
Riera, P:
 Hosp Santa Creu i St Pau, Genet Dept, Carrer St Antoni Maria Claret 167, Barcelona 08025, Spain

 UB, Fac Pharm & Food Sci, Barcelona, Spain

Salazar, J:
 Hosp Santa Creu i St Pau, Genet Dept, Carrer St Antoni Maria Claret 167, Barcelona 08025, Spain

 ISCIII, Ctr Biomed Res Rare Dis CIBERER, U705, Barcelona, Spain

Virgili, AC:
 Hosp Santa Creu i St Pau, Med Oncol Dept, Barcelona, Spain

Tobena, M:
 Hosp Santa Creu i St Pau, Med Oncol Dept, Barcelona, Spain

Sebio, A:
 Hosp Santa Creu i St Pau, Med Oncol Dept, Barcelona, Spain

Gallano, P:
 Hosp Santa Creu i St Pau, Genet Dept, Carrer St Antoni Maria Claret 167, Barcelona 08025, Spain

 ISCIII, Ctr Biomed Res Rare Dis CIBERER, U705, Barcelona, Spain

Barnadas, A:
 Hosp Santa Creu i St Pau, Med Oncol Dept, Barcelona, Spain

Paez, D:
 Hosp Santa Creu i St Pau, Med Oncol Dept, Barcelona, Spain
ISSN: 03065251





BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 84 Número: 6
Páginas: 1389-1392
WOS Id: 000434063100031
ID de PubMed: 29504153
imagen Green Published, Bronze

MÉTRICAS